Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Hep C Discussion Forum -> Knowledge/Info Section -> Monitoring: During and After Treatment
Post Info TOPIC: Monitoring: During and After Treatment
JimmyK


Guru

Status: Offline
Posts: 1839
Date:
RE: Monitoring: During and After Treatment
Permalink  
 

This is one of the best articles I have read here. It really does a good job of explaining, in easy to understand terms, the treatment process.

 

Thank you Tig.

 

JimmyK

 

 



__________________

Harvoni TX 2 12 weeks. UND weeks 4, 12 and now EOT + 4 Weeks. SVR-12 09/29/16. All Glory, Honor and Thanks be to God.

"I go to war with the brothers I trust."
wendyo


Guru

Status: Offline
Posts: 1031
Date:
Permalink  
 

Thanks Tig. Never saw an article like that. I have week 24 blood work next week so good timing!



__________________

Wendy 53 y/o, DX 1994, geno 1A F1

1999 TX 1 - Inter -non responder 2001 TX 2 - Peg + Riba - viral load tripled and taken off

T3:  Harvoni 12 weeks Sept. 19, 2015 ALT 41 AST 30 VL 541800 UND at EOT and SVR 24 ALT 18 AST 26 platelets 223

 
Tig


Admin

Status: Offline
Posts: 9270
Date:
Permalink  
 

Article on current monitoring of treatment efficacy during and after treatment. Addresses viral load detection during treatment and recommended testing protocol.

Core Concepts: Monitoring Tx Efficacy



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 
Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.
Hep C Discussion Forum -> Knowledge/Info Section -> Monitoring: During and After Treatment
Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.